Neuronal regulation of antitumor immunity

This federal Project Grant award, valued at $548,133.00 and awarded by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research at the University of Basel in Switzerland focused on "Neuronal Regulation of Antitumor Immunity". The award, which began on September 15, 2024 and is scheduled for completion by September 14, 2027, aims to conduct advanced biomedical research investigating the role of neuronal processes in modulating the body's immune response to tumors. As a foreign-owned, not-for-profit research institution, the University of Basel has a history of collaborating with U.S. federal agencies on various medical science and neurology projects through competitive grant awards. This particular grant demonstrates the university's expertise in areas such as cancer neuroscience, immunology, and computational modeling, with the potential to yield insights that could transform healthcare for military personnel and the general public.